122 related articles for article (PubMed ID: 326402)
1. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
De Palo GM; De Lena M; Bonadonna G
Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
[No Abstract] [Full Text] [Related]
2. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
[TBL] [Abstract][Full Text] [Related]
3. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
[No Abstract] [Full Text] [Related]
4. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
[No Abstract] [Full Text] [Related]
7. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
8. Use of tissue culture in predictive testing of drug sensitivity in human ovarian cancer. Correlation between in vitro results and the response in vivo.
Tropé C; Sigurdsson K
Neoplasma; 1982; 29(3):309-14. PubMed ID: 7133226
[TBL] [Abstract][Full Text] [Related]
9. Melphalan with and without doxorubicin in advanced ovarian cancer.
Tropé C
Obstet Gynecol; 1987 Oct; 70(4):582-6. PubMed ID: 3306509
[TBL] [Abstract][Full Text] [Related]
10. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
12. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L
Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.
Bonomi PD; Slayton RE; Wolter J
Cancer Treat Rep; 1978 Aug; 62(8):1211-3. PubMed ID: 356979
[No Abstract] [Full Text] [Related]
14. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
15. [Preliminary report on the treatment of ovarian cancer with adriamycin following full conventional treatment (author's transl)].
Wolf A; Vahrson H
Geburtshilfe Frauenheilkd; 1977 Mar; 37(3):224-7. PubMed ID: 858485
[TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE
Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056
[TBL] [Abstract][Full Text] [Related]
17. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
Izbicki RM; Amer MH; Al-Sarraf M
Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined.
Guthrie D; Way S
Obstet Gynecol; 1974 Oct; 44(4):586-9. PubMed ID: 4547341
[No Abstract] [Full Text] [Related]
19. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
Gershanovich ML; Livshits ME; Antipenkova VI
Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]